1Cazenave JP,Isola H, Gachet C, et al. Progress in transfusion for storage of platelets[J]. Transfus Clin Biol, 2005,12(2): 226-229.
2Connor J, Currie LM, Allan H, et al. Recovery of in vitro functional activity of platelet concentrates stored at 4 ℃ and treated with second-messenger effectors [J]. Transfusion, 1996, 36 ( 8 ) : 691- 698.
3Gulliksson H, AuBuchon JP, Vesterinen M, et al. Storage of platelets in additive solutions:a pilot in vitro study of the effects of potassium and magnesium[J]. Vox Sang, 2002,82(8) :131 -136.
4Murphy S, Shimizu T, Miripol J. Platelet storage for transfusion in synthetic media:further optimization of ingredients and definition of their roles[J].Blood, 1995,86 (10) : 3951-3960.
5Moroff G, Wagner S, Benade L, et al. Factors influencing virus inactivation and retention of platelet properties following treatment with aminomethyltrimethylpsoralen and ultraviolet A light[J]. Blood Cells,1992,18(1) :43-56.
6Hole S, Moroff G, Murphy S, et al. A multilaboratory evaluation of in vitro platelet assays:the tests fo rextent of shape change and response to hypotonie shock[J]. Vox Sanguinis, 2004,86 (3) : 214- 216.
7Garcia -Martinez MC, Manuel L, Carlos H, et al. The effect of hormone replacement therapy on Ca^2+ mobilization and P- selectin (CD62p) expression in platelets examined under flow cytometry [J]. Vox Sanguinis,2004,15(1) :1-8.
7Blumber GN,Heal JM,Gettings KF.WBC reduction of RBC transfusions is associated with a decreesed incidence of RBC alloimmunodel[J].Blood,2005,105(2):847-854.
10Blumber GN, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decressed incidence of RBC allo- immunodel[J]. Blood,2005,105(2) :847- 854.
